Study of the Prednisone Sparing Effect of Xolair (Omalizumab) in Patients With Prednisone-dependent Asthma With Eosinophilic Bronchitis

Conditions:   Prednisone Dependent Asthma;   Eosinophilic Bronchitis
Interventions:   Biological: Omalizumab (Xolair);   Drug: Placebo
Sponsors:   McMaster University;   Parameswaran Nair;   Novartis
Not yet recruiting – verified January 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.